Literature DB >> 2886594

Interactions of trimebutine with guinea-pig opioid receptors.

F Roman, X Pascaud, J E Taylor, J L Junien.   

Abstract

Affinities of trimebutine (TMB) and N-desmethyl trimebutine (NDTMB) for mu, delta and kappa opioid receptor subtypes have been examined using specific 3H-ligands and guinea-pig membrane. TMB and NDTMB showed a relative higher affinity for the mu receptor subtype although they were, respectively, 30- and 48-fold less active than morphine. The receptor selectivity index for mu, delta and kappa were 100:12:14.4 for TMB, 100:32:25 for NDTMB and 100:5:5 for morphine. The sodium shift ratio was 14 for TMB, 10 for NDTMB and 37 for morphine. These data show that (unlike morphine, a pure mu agonist) TMB and NDTMB can be classified as weak opioid agonists and confirm that peripheral opioid receptors mediate their gastrointestinal motility effects.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2886594     DOI: 10.1111/j.2042-7158.1987.tb03409.x

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  2 in total

Review 1.  Centrally acting agents and visceral sensitivity.

Authors:  J Fioramonti; L Bueno
Journal:  Gut       Date:  2002-07       Impact factor: 23.059

2.  Repositioning Trimebutine Maleate as a Cancer Treatment Targeting Ovarian Cancer Stem Cells.

Authors:  Heejin Lee; Oh-Bin Kwon; Jae-Eon Lee; Yong-Hyun Jeon; Dong-Seok Lee; Sang-Hyun Min; Jun-Woo Kim
Journal:  Cells       Date:  2021-04-16       Impact factor: 6.600

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.